Cite
MFN2-associated lipomatosis: Clinical spectrum and impact on adipose tissue.
MLA
Capel, Emilie, et al. “MFN2-Associated Lipomatosis: Clinical Spectrum and Impact on Adipose Tissue.” Journal of Clinical Lipidology, vol. 12, no. 6, Nov. 2018, pp. 1420–35. EBSCOhost, https://doi.org/10.1016/j.jacl.2018.07.009.
APA
Capel, E., Vatier, C., Cervera, P., Stojkovic, T., Disse, E., Cottereau, A.-S., Auclair, M., Verpont, M.-C., Mosbah, H., Gourdy, P., Barraud, S., Miquel, A., Züchner, S., Bonnefond, A., Froguel, P., Christin-Maitre, S., Delemer, B., Fève, B., Laville, M., & Robert, J. (2018). MFN2-associated lipomatosis: Clinical spectrum and impact on adipose tissue. Journal of Clinical Lipidology, 12(6), 1420–1435. https://doi.org/10.1016/j.jacl.2018.07.009
Chicago
Capel, Emilie, Camille Vatier, Pascale Cervera, Tanya Stojkovic, Emmanuel Disse, Anne-Ségolène Cottereau, Martine Auclair, et al. 2018. “MFN2-Associated Lipomatosis: Clinical Spectrum and Impact on Adipose Tissue.” Journal of Clinical Lipidology 12 (6): 1420–35. doi:10.1016/j.jacl.2018.07.009.